Across TCGA pan-cancer cohorts, GRXCR1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GRXCR1 data layer compared with 11 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher GRXCR1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GRXCR1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

LUAD and SKCM are the cancer types where GRXCR1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.090	0.709	<.001	12	view →
SKCM	DFS	Median	II,III,IV	0.829	0.673	.033	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GRXCR1 tumor-vs-normal RNA expression · all GRXCR1 data types